352 related articles for article (PubMed ID: 8104920)
21. Oncogenes and tumour suppressor genes in first trimester human fetal gonadal development.
Quenby SM; Gazvani MR; Brazeau C; Neilson J; Lewis-Jones DI; Vince G
Mol Hum Reprod; 1999 Aug; 5(8):737-41. PubMed ID: 10421801
[TBL] [Abstract][Full Text] [Related]
22. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
Wei Z; Wu Y; Zhai Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
[TBL] [Abstract][Full Text] [Related]
23. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
24. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
[TBL] [Abstract][Full Text] [Related]
25. Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression.
Albertazzi E; Cajone F; Leone BE; Naguib RN; Lakshmi MS; Sherbet GV
DNA Cell Biol; 1998 Apr; 17(4):335-42. PubMed ID: 9570150
[TBL] [Abstract][Full Text] [Related]
26. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
27. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
[TBL] [Abstract][Full Text] [Related]
28. Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis.
Sastre-Garau X; Lacombe ML; Jouve M; Véron M; Magdelénat H
Int J Cancer; 1992 Feb; 50(4):533-8. PubMed ID: 1537618
[TBL] [Abstract][Full Text] [Related]
29. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
30. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
31. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
32. Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein.
Han S; Yun IJ; Noh DY; Choe KJ; Song SY; Chi JG
J Surg Oncol; 1997 May; 65(1):22-7. PubMed ID: 9179263
[TBL] [Abstract][Full Text] [Related]
33. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
[TBL] [Abstract][Full Text] [Related]
34. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.
Machotka SV; Garrett CT; Schwartz AM; Callahan R
Clin Chim Acta; 1989 Oct; 184(3):207-17. PubMed ID: 2611995
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
36. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
37. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
Charpin C; Bouvier C; Garcia S; Martini F; Andrac L; Lavaut MN; Allasia C
Int J Cancer; 1997 Aug; 74(4):416-20. PubMed ID: 9291431
[TBL] [Abstract][Full Text] [Related]
38. Multiple genetic lesions in laryngeal squamous cell carcinomas.
Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases.
Tsuda H; Sakamaki C; Tsugane S; Fukutomi T; Hirohashi S
Breast Cancer Res Treat; 1998 Mar; 48(1):21-32. PubMed ID: 9541186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
